Vaccine responses to conserved regions of the HIV-1 proteome are associated with an increased capacity to inhibit multiple virus isolates ex vivo

por Ashraf, A, Kopycinski, J, Cheeseman, H, Lala, F, Czyzewska-Khan, J, Spentzou, A, Gill, DK, Keefer, M, Excler, J, Fast, P, Hayes, P, Cox, JH, Gilmour, J
Publicado 2012

OA05-01. In vivo electroporation enhances the immunogenicity of ADVAX, a DNA-based HIV-1 vaccine candidate, in healthy volunteers

por Vasan, S, Hurley, A, Schlesinger, SJ, Hannaman, D, Gardiner, DF, Dugin, DP, Boente-Carrera, MM, Vittorino, RM, Caskey, M, Andersen, J, Huang, Y, Cox, J, Tarragona, T, Gill, DK, Cheeseman, H, Clark, L, Dally, L, Smith, C, Schmidt, C, Park, H, Sayeed, E, Gilmour, J, Fast, P, Bernard, R, Ho, DD
Publicado 2009